Debt-to-equity of RELMADA THERAPEUTICS, INC. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
RELMADA THERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • RELMADA THERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 31%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

RELMADA THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 31% 30 Sep 2025
Q2 2025 24% 30 Jun 2025
Q4 2019 7% +191% 31 Dec 2019
Q3 2019 59% +261% 30 Sep 2019
Q2 2019 2009% +2464% 30 Jun 2019
Q1 2019 -186% -1576% -113% 31 Mar 2019
Q4 2018 -185% -382% -193% 31 Dec 2018
Q3 2018 -202% -283% -348% 30 Sep 2018
Q2 2018 -455% -501% -1094% 30 Jun 2018
Q1 2018 1390% +1348% +3198% 31 Mar 2018
Q4 2017 198% +163% +465% 31 Dec 2017
Q3 2017 81% +44% +118% 30 Sep 2017
Q2 2017 46% 30 Jun 2017
Q1 2017 42% 31 Mar 2017
Q4 2016 35% 31 Dec 2016
Q3 2016 37% 30 Sep 2016
Q2 2015 -2439% 30 Jun 2015
Q1 2015 -875% 31 Mar 2015
Q4 2014 -411% 31 Dec 2014
Q3 2014 -217% 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.